The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment
- 1 January 1997
- journal article
- other
- Published by SAGE Publications in Journal of Health Services Research & Policy
- Vol. 2 (1), 26-30
- https://doi.org/10.1177/135581969700200107
Abstract
The Economic evaluation of health care technologies has a key role within the new National Health Service health technology assessment process. There has, however, been little discussion of the best way of combining economic and clinical research. Economic evaluation should be iterative, generating progressively firmer estimates of cost-effectiveness and helping to maximise the efficiency of health care R&D. Here, four stages of economic analysis are suggested, starting with stage I when the basic clinical science is complete, and finishing with stage IV analysis to generalise the results of earlier studies to routine clinical practice.Keywords
This publication has 14 references indexed in Scilit:
- Large-scale randomized evidence: Large, simple trials and overviews of trialsJournal of Clinical Epidemiology, 1995
- Statistical Versus Quantitative Significance in the Socioeconomic Evaluation of MedicinesPharmacoEconomics, 1994
- An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagiaBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.BMJ, 1992
- Randomised controlled trial of cost-effectiveness of lithotripsy and open cholecystectomy as treatments for gallbladder stonesThe Lancet, 1992
- A Model for Evaluating the Cost-Effectiveness of Cholesterol-Lowering TreatmentInternational Journal of Technology Assessment in Health Care, 1992
- Cost-Effectiveness of Strategies for Detecting Diabetic RetinopathyMedical Care, 1991
- Economic Analysis Alongside Clinical Trials: Revisiting the Methodological IssuesInternational Journal of Technology Assessment in Health Care, 1991
- Analysis of The National Institutes of Health Medicare Coverage AssessmentInternational Journal of Technology Assessment in Health Care, 1990
- Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: The case of simvastatin and cholestyramine in The NetherlandsThe American Journal of Cardiology, 1990